Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

January 31, 2018 | Daily News

During his first State of the Union address on Tuesday (Jan. 30), President Donald Trump said his plans for immigration reform will help curb the opioid epidemic, but lawmakers and industry stakeholders said more needs to be done and some took issue with the Trump administration's continued lack of dedicated funding to help solve the crisis.

January 31, 2018 | Daily News

President Donald Trump said during the State of the Union speech that he has directed his administration to cut drug prices, but the one measure the Trump CMS has taken on drug prices will have the opposite effect, according to nonpartisan congressional Medicare advisers, and Trump gave no indication of how he plans to go about lowering prices. Some Republicans said they’re a little concerned by the statement, but others say they agree the government should control prices and they think boosting generics is the way to do it.

January 30, 2018 | Daily News

President Donald Trump in his first State of the Union Address trumpeted the repeal of Obamacare's individual mandate; repeated his vow to cut prescription drug prices; held up FDA's increased approval of new and generic drugs and medical devices; asked Congress to pass “Right to Try” legislation giving patients immediate access to experimental drugs; and pledged to fight the opioid epidemic.

January 30, 2018 | Daily News

The health care sector was abuzz Tuesday (Jan. 30) over news that Amazon, JP Morgan and Berkshire Hathaway will partner to create a new healthcare entity, and while traditional health insurance stocks took a dive following the announcement, as did those of pharmacy benefit managers, health experts and analyst said it was too early to speculate on how the entity would impact the health space.

January 30, 2018 | Daily News

FDA on Tuesday (Jan. 30) took what FDA Commissioner Scott Gottlieb painted as “unprecedented and novel action” by calling on marketers of drugs with a potential for abuse and misuse to voluntarily take steps to address public health issues, and specifically asked Imodium A-D makers to change their packaging.

January 30, 2018 | Daily News

The House Energy & Commerce Committee on Feb. 26 will hold its first hearing this year on ways to combat the opioid crisis, with a focus on new treatments and disposal options.

January 30, 2018 | Daily News

FDA recently launched a pilot program under which it will publish the clinical evidence used to support approval of a subset of new drug applications (NDAs).

January 29, 2018 | Daily News

FDA will hold a public meeting to discuss how to improve eligibility criteria for clinical trials to better represent the broader patient population and increase diversity, the agency announced Monday (Jan. 29).

January 26, 2018 | Daily News

Circumstances are good for administrative changes to Part B drug reimbursement, former Obama administration official Kavita Patel said, and Pew Charitable Trusts Senior Director of Health Programs Allan Coukell said newly confirmed HHS chief Alex Azar has a few tools he could use to curb drug-spending increases without help from Congress.

January 26, 2018 | Daily News

A bipartisan group of 20 senators is urging CMS to move forward with its informal proposal to make plans share drug rebates with consumers and ban pharmacy price concessions, but Republican chairs of Senate and House committees warn CMS against making those policy changes without going through the public rulemaking process.

January 26, 2018 | Daily News

Only three weeks into 2018, lawmakers in 20 states have introduced 43 bills aimed at curbing Medicaid drug spending, according to the National Academy for State Health Policy.

January 25, 2018 | Daily News

Attorneys for the generic drug industry and Maryland jostled over the scope of the state's first-in-the-nation generic drug price gouging law during oral arguments Wednesday (Jan. 24) in their ongoing legal battle over the law.

January 25, 2018 | Daily News

The Senate health committee on Thursday (Feb. 8) will hold its fourth hearing on the opioid crisis, focusing on the effects the crisis has on children and families and how states are taking action to ensure infants affected by drug abuse are taken care of.

January 25, 2018 | Daily News

A working group of prescribers, dispensers, manufacturers and professional societies is pushing a slate of reforms to help curb the opioid epidemic, which includes supporting funding to upgrade prescription drug monitoring program (PDMP) technology, expanding substance use disorder treatment options and ensuring patients' medical history is available in real-time so that providers and pharmacists have access to patient information.

January 25, 2018 | Daily News

Endo Pharmaceuticals has agreed to a temporary stay of its lawsuit against FDA over the agency's interim policy on compounding using bulk substances until the agency releases new guidance to significantly rework the controversial policy.

January 25, 2018 | Daily News

In the wake of a controversial policy that ended up getting the agency sued, FDA announced it will release new guidance in March on determining the clinical need to warrant compounding using bulk substances, which one source familiar with the drafting and negotiations around the compounding law says could “right the ship” on bulk compounding.

January 25, 2018 | Daily News

Health system pharmacists are largely in the dark on how to comply with FDA's compounding regulations, but the industry hopes that will change in light of FDA's newly announced plan to release guidance on how it will apply compounding regulations to this sector.

January 25, 2018 | Daily News

Health system pharmacists are largely in the dark on how to comply with FDA's compounding regulations, but the industry hopes that will change in light of FDA's newly announced plan to release guidance on how it will apply compounding regulations to this sector.

January 25, 2018 | Daily News

Current oversight and regulation of the outsourcing compounding industry is insufficient and enforcement of the current guidelines is too lax, according to a recent white paper that came out of roundtable discussions with top compounding experts.

January 25, 2018 | Daily News

Current oversight and regulation of the outsourcing compounding industry is insufficient and enforcement of the current guidelines is too lax, according to a recent white paper that came out of roundtable discussions with top compounding experts.

Pages